Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy (Q33496078)

27 July 2017

1 reference

title

Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy (English)

1 reference

27 July 2017

1 reference

2

Remuzzi G

1 reference

27 July 2017

1

Ruggenenti P

1 reference

27 July 2017

publication date

1 April 1996

1 reference

American Journal of Kidney Diseases

27 July 2017

published in

1 reference

27 July 2017

volume

27

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

459-475

1 reference

Ocular involvement in hemolytic-uremic syndrome

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The role of genetic factors in the development of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Glomeruli and blood pressure. Less of one, more the other?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Renal Vasculature in Essential Hypertension: Racial Differences

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Target organ damage in black hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Age, race, sex and other indices of risk in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Letter: Racial disparity of plasma volume in hypertensive man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Sodium sensitivity and resistance in normotensive humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Race and socioeconomic status in hypertension and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Socioeconomic status and end-stage renal disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The protean manifestations of renal vein thrombosis in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Oliguric acute renal failure in malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Normotensive renal failure in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Renal biopsies in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

STUDIES ON EXPERIMENTAL HYPERTENSION : VII. THE PRODUCTION OF THE MALIGNANT PHASE OF HYPERTENSION.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The endothelium: its role in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Endothelial injury in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

A Vascular Permeability Factor of Renal Origin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Effects of angiotensin II and some analogues on vascular permeability in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Skin capillary blood flow in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The kidney in progressive systemic sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The kidney of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Hemodynamics and the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Role of von Willebrand factor in platelet adhesion to the subendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Scleroderma and Microangiopathic Hemolytic Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Detection of renovascular hypertension. State of the art: 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Management of hypertensive emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Urgent bilateral nephrectomy for severe hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Racial factors in the incidence and causation of end-stage renal disease (ESRD).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Clinical course of patients with scleroderma renal crisis treated with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The management of renal scleroderma: experience with dialysis, nephrectomy and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Bilateral nephrectomy: its role in management of the malignant hypertension of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Bilateral nephrectomy for malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Hemodialysis and kidney transplantation for renal failure from scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Successful renal transplantation in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Renal transplantation for progressive systemic sclerosis with renal failure: case report and review of previous experience

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

The hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme Blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Reversal of Scleroderma Renal Crisis for More Than Two Years in a Patient Treated with Captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Control of hypertension and reversal of renal failure in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Successful medical treatment of scleroderma renal crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Reversal of severe renal failure in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Use of captopril as early therapy for renal scleroderma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990155-9

7 January 2021

10.1016/S0272-6386(96)90155-9

Identifiers

DOI

1 reference

27 July 2017

1 reference